Work

Phase 1–2a dose ranging study of TLK286 (a novel glutathione analog) in combination with docetaxel in platinum-resistant non-small cell lung cancer (NSCLC)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7140

Authors: V. Papadimitrakopoulou, P. Boasberg, R. Figlin, R. Zinner, G. Blumenschein, L. King, M. Truong, K. Patel, G. L. Brown, N. Hanna

Institutions: The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Telik, Inc. (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601322317

Cites:

Cited by: 5

Related to: 10